Search

everythinglearnresearchcommunity

for

Search:↓

Diphenylcyclopropenone (DPCP) is more effective than anthralin for treating resistant alopecia areata.

Some patients on anti-TNF drugs experience a type of hair loss called TAIAPA.

Alopecia areata and atopic dermatitis share immune system issues, and treatments like JAK inhibitors can help both.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

Apremilast showed mixed results for treating severe alopecia areata.

Tofacitinib may help treat Lichen Planopilaris, but more research is needed.

Medicaid coverage for alopecia areata treatments is inconsistent and often limited.

Belimumab reduces disease activity, steroid use, and flares in lupus patients.

Upadacitinib effectively treats pyoderma gangrenosum.

Tofacitinib helped a woman with total-body hair loss grow her hair back.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

Baricitinib and ritlecitinib are recommended for severe alopecia areata, with other treatments available off-label.

Ritlecitinib and baricitinib are effective for alopecia areata, but more research is needed to determine which is better.

Rituximab improved her dermatomyositis better than usual treatments.

Methylprednisolone treatment helps most alopecia areata patients, but young age, extensive hair loss, and low vitamin D can affect results.

The NUDT15 gene variant causes severe side effects from azathioprine in some Indian patients.

Using a higher concentration of triamcinolone acetonide leads to faster hair regrowth in scalp patchy alopecia areata.

The document concluded that various dermatological treatments have different effectiveness and side effects, with some causing irritation, allergic reactions, or systemic effects.

Triamcinolone acetonide mesotherapy may be effective for treating patchy hair loss in alopecia areata.

Intralesional triamcinolone acetonide effectively treats alopecia areata, as shown by significant improvements in hair regrowth and dermoscopic indicators.

Researchers found three different ways drugs work to treat hair loss from alopecia areata and identified key factors for personalized treatment.

Amivantamab can cause severe skin eruptions and scarring, requiring drug discontinuation and early treatment.

Tralokinumab for atopic dermatitis may cause side effects like dizziness, headache, nausea, hair loss, and acne.

A new microneedle patch effectively treats atopic dermatitis by reducing skin stress and restoring immune balance.

DM and AA may share a common cause.

Mycophenolate mofetil helped reduce steroid use in treating a dog's autoimmune skin disease.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

The registry showed that tofacitinib is promising for treating hair loss in children with alopecia areata, but more research is needed.

A woman got a scalp condition from using latanoprost, but it improved after stopping the drug and starting other treatments.

Methotrexate is a promising and safe treatment for severe alopecia areata, with better results when combined with corticosteroids.